Home/Filings/4/0001437749-24-014447
4//SEC Filing

Sharman John Stewart 4

Accession 0001437749-24-014447

CIK 0001279695other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 6:23 AM ET

Size

15.3 KB

Accession

0001437749-24-014447

Insider Transaction Report

Form 4
Period: 2024-05-01
Sharman John Stewart
Chief Executive Officer
Transactions
  • Award

    Common Stock

    2024-05-01$0.15/sh+23,055$3,458103,055 total
  • Award

    Common Stock

    2024-05-01$0.15/sh+30,000$4,500394,666 total(indirect: By superannuation fund)
  • Award

    Common Stock

    2024-05-01$0.15/sh+10,000$1,5001,286,217 total(indirect: By Spouse)
Holdings
  • Performance Rights

    Exp: 2025-03-24Common Stock (2,500,000 underlying)
    2,500,000
  • Performance Rights

    Exp: 2025-03-24Common Stock (1,250,000 underlying)
    1,250,000
  • Stock Option (Right to Buy)

    Exercise: $0.25Exp: 2025-03-24Common Stock (2,364,667 underlying)
    2,364,667
  • Stock Option (Right to Buy)

    Exercise: $0.30Exp: 2025-03-24Common Stock (1,364,667 underlying)
    1,364,667
  • Stock Option (Right to Buy)

    (indirect: By superannuation fund)
    Exercise: $0.30Exp: 2025-03-24Common Stock (1,000,000 underlying)
    1,000,000
Footnotes (6)
  • [F1]The reporting person disclaims beneficial ownership of the shares held by his wife except to the extent of his pecuniary interest therein, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
  • [F2]The price reported is stated in Australian dollars.
  • [F3]The reporting person disclaims beneficial ownership of the shares held by his superannuation except to the extent of his pecuniary interest therein, and this report should not be deemed an admission that the reporting person is the beneficial owner of his superannuation funds shares for purposes of Section 16 or for any other purpose.
  • [F4]Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
  • [F5]Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.
  • [F6]These options are fully vested and became exercisable after September 24, 2020.

Issuer

UNIVERSAL BIOSENSORS INC

CIK 0001279695

Entity typeother

Related Parties

1
  • filerCIK 0001812991

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 6:23 AM ET
Size
15.3 KB